Harmony Biosciences Holdings Inc (NASDAQ: HRMY) on Tuesday, soared 4.09% from the previous trading day, before settling in for the closing price of $35.25. Within the past 52 weeks, HRMY’s price has moved between $26.47 and $41.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 24.72%. With a float of $43.61 million, this company’s outstanding shares have now reached $57.39 million.
The firm has a total of 268 workers. Let’s measure their productivity. In terms of profitability, gross margin is 77.54%, operating margin of 26.18%, and the pretax margin is 26.47%.
Harmony Biosciences Holdings Inc (HRMY) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Harmony Biosciences Holdings Inc is 24.06%, while institutional ownership is 79.03%. The most recent insider transaction that took place on Jun 10 ’25, was worth 202,009. Before that another transaction happened on May 19 ’25, when Company’s Former Officer proposed sale 9,844 for $35.56, making the entire transaction worth $350,083.
Harmony Biosciences Holdings Inc (HRMY) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.72% per share during the next fiscal year.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Trading Performance Indicators
Harmony Biosciences Holdings Inc (HRMY) is currently performing well based on its current performance indicators. A quick ratio of 3.63 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.83. Likewise, its price to free cash flow for the trailing twelve months is 9.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.62, a number that is poised to hit 0.74 in the next quarter and is forecasted to reach 4.01 in one year’s time.
Technical Analysis of Harmony Biosciences Holdings Inc (HRMY)
Analysing the last 5-days average volume posted by the [Harmony Biosciences Holdings Inc, HRMY], we can find that recorded value of 0.68 million was better than the volume posted last year of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 65.63%.
During the past 100 days, Harmony Biosciences Holdings Inc’s (HRMY) raw stochastic average was set at 95.16%, which indicates a significant increase from 90.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.07 in the past 14 days, which was lower than the 1.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.99, while its 200-day Moving Average is $34.09. Now, the first resistance to watch is $37.20. This is followed by the second major resistance level at $37.72. The third major resistance level sits at $38.69. If the price goes on to break the first support level at $35.71, it is likely to go to the next support level at $34.74. Now, if the price goes above the second support level, the third support stands at $34.22.
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) Key Stats
Market capitalization of the company is 2.11 billion based on 57,424K outstanding shares. Right now, sales total 714,730 K and income totals 145,490 K. The company made 184,730 K in profit during its latest quarter, and 45,560 K in sales during its previous quarter.
